nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—ABCB1—Topotecan—cervical cancer	0.396	0.625	CbGbCtD
Betamethasone—CYP3A4—Topotecan—cervical cancer	0.237	0.375	CbGbCtD
Betamethasone—PLA2G1B—exocrine gland—cervical cancer	0.0378	0.105	CbGeAlD
Betamethasone—CYP19A1—semen—cervical cancer	0.037	0.103	CbGeAlD
Betamethasone—PLA2G1B—epithelium—cervical cancer	0.0164	0.0459	CbGeAlD
Betamethasone—PLA2G1B—renal system—cervical cancer	0.0152	0.0425	CbGeAlD
Betamethasone—PLA2G1B—female reproductive system—cervical cancer	0.0122	0.0341	CbGeAlD
Betamethasone—PLA2G1B—female gonad—cervical cancer	0.0111	0.031	CbGeAlD
Betamethasone—NR3C2—uterine cervix—cervical cancer	0.00807	0.0225	CbGeAlD
Betamethasone—PGR—epithelium—cervical cancer	0.00757	0.0211	CbGeAlD
Betamethasone—NR3C2—renal system—cervical cancer	0.00755	0.0211	CbGeAlD
Betamethasone—PGR—uterine cervix—cervical cancer	0.0075	0.0209	CbGeAlD
Betamethasone—NR3C2—endometrium—cervical cancer	0.0073	0.0204	CbGeAlD
Betamethasone—PGR—decidua—cervical cancer	0.00715	0.0199	CbGeAlD
Betamethasone—NR3C2—mammalian vulva—cervical cancer	0.00706	0.0197	CbGeAlD
Betamethasone—PGR—endometrium—cervical cancer	0.00679	0.0189	CbGeAlD
Betamethasone—NR3C2—uterus—cervical cancer	0.00673	0.0188	CbGeAlD
Betamethasone—PGR—uterus—cervical cancer	0.00625	0.0174	CbGeAlD
Betamethasone—CYP19A1—endometrium—cervical cancer	0.00611	0.017	CbGeAlD
Betamethasone—NR3C2—female reproductive system—cervical cancer	0.00605	0.0169	CbGeAlD
Betamethasone—CYP19A1—uterus—cervical cancer	0.00563	0.0157	CbGeAlD
Betamethasone—PGR—female reproductive system—cervical cancer	0.00562	0.0157	CbGeAlD
Betamethasone—NR3C2—female gonad—cervical cancer	0.0055	0.0153	CbGeAlD
Betamethasone—NR3C2—vagina—cervical cancer	0.00547	0.0153	CbGeAlD
Betamethasone—PGR—female gonad—cervical cancer	0.00511	0.0143	CbGeAlD
Betamethasone—PGR—vagina—cervical cancer	0.00508	0.0142	CbGeAlD
Betamethasone—CYP19A1—female reproductive system—cervical cancer	0.00506	0.0141	CbGeAlD
Betamethasone—CYP19A1—female gonad—cervical cancer	0.0046	0.0128	CbGeAlD
Betamethasone—NR3C1—epithelium—cervical cancer	0.00437	0.0122	CbGeAlD
Betamethasone—NR3C1—uterine cervix—cervical cancer	0.00433	0.0121	CbGeAlD
Betamethasone—NR3C1—decidua—cervical cancer	0.00412	0.0115	CbGeAlD
Betamethasone—NR3C1—renal system—cervical cancer	0.00405	0.0113	CbGeAlD
Betamethasone—NR3C1—endometrium—cervical cancer	0.00392	0.0109	CbGeAlD
Betamethasone—NR3C1—mammalian vulva—cervical cancer	0.00379	0.0106	CbGeAlD
Betamethasone—PTGS2—epithelium—cervical cancer	0.00378	0.0105	CbGeAlD
Betamethasone—PTGS2—uterine cervix—cervical cancer	0.00375	0.0105	CbGeAlD
Betamethasone—NR3C1—uterus—cervical cancer	0.00361	0.0101	CbGeAlD
Betamethasone—NR3C2—lymph node—cervical cancer	0.00354	0.00987	CbGeAlD
Betamethasone—PTGS2—renal system—cervical cancer	0.0035	0.00978	CbGeAlD
Betamethasone—PTGS2—endometrium—cervical cancer	0.00339	0.00945	CbGeAlD
Betamethasone—PGR—lymph node—cervical cancer	0.00329	0.00917	CbGeAlD
Betamethasone—NR3C1—female reproductive system—cervical cancer	0.00324	0.00905	CbGeAlD
Betamethasone—PTGS2—uterus—cervical cancer	0.00312	0.00871	CbGeAlD
Betamethasone—CYP3A4—renal system—cervical cancer	0.00306	0.00854	CbGeAlD
Betamethasone—CYP19A1—lymph node—cervical cancer	0.00296	0.00825	CbGeAlD
Betamethasone—NR3C1—female gonad—cervical cancer	0.00295	0.00823	CbGeAlD
Betamethasone—NR3C1—vagina—cervical cancer	0.00293	0.00818	CbGeAlD
Betamethasone—PTGS2—female reproductive system—cervical cancer	0.00281	0.00783	CbGeAlD
Betamethasone—PTGS2—female gonad—cervical cancer	0.00255	0.00712	CbGeAlD
Betamethasone—PTGS2—vagina—cervical cancer	0.00254	0.00708	CbGeAlD
Betamethasone—CYP3A4—female reproductive system—cervical cancer	0.00245	0.00684	CbGeAlD
Betamethasone—ABCB1—epithelium—cervical cancer	0.00234	0.00652	CbGeAlD
Betamethasone—ABCB1—uterine cervix—cervical cancer	0.00232	0.00646	CbGeAlD
Betamethasone—ABCB1—decidua—cervical cancer	0.00221	0.00616	CbGeAlD
Betamethasone—ABCB1—renal system—cervical cancer	0.00217	0.00605	CbGeAlD
Betamethasone—ABCB1—endometrium—cervical cancer	0.0021	0.00585	CbGeAlD
Betamethasone—ABCB1—mammalian vulva—cervical cancer	0.00203	0.00566	CbGeAlD
Betamethasone—ABCB1—uterus—cervical cancer	0.00193	0.00539	CbGeAlD
Betamethasone—NR3C1—lymph node—cervical cancer	0.0019	0.00529	CbGeAlD
Betamethasone—ABCB1—female reproductive system—cervical cancer	0.00174	0.00484	CbGeAlD
Betamethasone—PTGS2—lymph node—cervical cancer	0.00164	0.00458	CbGeAlD
Betamethasone—ABCB1—female gonad—cervical cancer	0.00158	0.00441	CbGeAlD
Betamethasone—ABCB1—vagina—cervical cancer	0.00157	0.00438	CbGeAlD
Betamethasone—ABCB1—lymph node—cervical cancer	0.00102	0.00283	CbGeAlD
Betamethasone—Rash erythematous—Topotecan—cervical cancer	0.00053	0.0683	CcSEcCtD
Betamethasone—Extravasation—Topotecan—cervical cancer	0.000465	0.06	CcSEcCtD
Betamethasone—Neuropathy—Topotecan—cervical cancer	0.000381	0.0491	CcSEcCtD
Betamethasone—Dermatitis bullous—Topotecan—cervical cancer	0.000308	0.0397	CcSEcCtD
Betamethasone—Anaphylactoid reaction—Topotecan—cervical cancer	0.000304	0.0392	CcSEcCtD
Betamethasone—Lethargy—Topotecan—cervical cancer	0.0003	0.0387	CcSEcCtD
Betamethasone—Cardiac arrest—Topotecan—cervical cancer	0.00028	0.0361	CcSEcCtD
Betamethasone—Weight increased—Topotecan—cervical cancer	0.000232	0.0299	CcSEcCtD
Betamethasone—Neuropathy peripheral—Topotecan—cervical cancer	0.000222	0.0287	CcSEcCtD
Betamethasone—Haemoglobin—Topotecan—cervical cancer	0.000205	0.0264	CcSEcCtD
Betamethasone—Haemorrhage—Topotecan—cervical cancer	0.000204	0.0263	CcSEcCtD
Betamethasone—Angiopathy—Topotecan—cervical cancer	0.000185	0.0238	CcSEcCtD
Betamethasone—Alopecia—Topotecan—cervical cancer	0.00018	0.0232	CcSEcCtD
Betamethasone—Ill-defined disorder—Topotecan—cervical cancer	0.000164	0.0212	CcSEcCtD
Betamethasone—Angioedema—Topotecan—cervical cancer	0.000162	0.0209	CcSEcCtD
Betamethasone—Malaise—Topotecan—cervical cancer	0.00016	0.0206	CcSEcCtD
Betamethasone—Myalgia—Topotecan—cervical cancer	0.000151	0.0195	CcSEcCtD
Betamethasone—Discomfort—Topotecan—cervical cancer	0.000149	0.0192	CcSEcCtD
Betamethasone—Anaphylactic shock—Topotecan—cervical cancer	0.000145	0.0187	CcSEcCtD
Betamethasone—Infection—Topotecan—cervical cancer	0.000144	0.0185	CcSEcCtD
Betamethasone—Nervous system disorder—Topotecan—cervical cancer	0.000142	0.0183	CcSEcCtD
Betamethasone—Thrombocytopenia—Topotecan—cervical cancer	0.000142	0.0183	CcSEcCtD
Betamethasone—Hyperhidrosis—Topotecan—cervical cancer	0.00014	0.018	CcSEcCtD
Betamethasone—Anorexia—Topotecan—cervical cancer	0.000138	0.0178	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Topotecan—cervical cancer	0.000132	0.017	CcSEcCtD
Betamethasone—Paraesthesia—Topotecan—cervical cancer	0.00013	0.0168	CcSEcCtD
Betamethasone—Dyspepsia—Topotecan—cervical cancer	0.000127	0.0164	CcSEcCtD
Betamethasone—Decreased appetite—Topotecan—cervical cancer	0.000126	0.0162	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Topotecan—cervical cancer	0.000125	0.0161	CcSEcCtD
Betamethasone—Fatigue—Topotecan—cervical cancer	0.000125	0.0161	CcSEcCtD
Betamethasone—Pain—Topotecan—cervical cancer	0.000124	0.016	CcSEcCtD
Betamethasone—Feeling abnormal—Topotecan—cervical cancer	0.000119	0.0154	CcSEcCtD
Betamethasone—Gastrointestinal pain—Topotecan—cervical cancer	0.000118	0.0153	CcSEcCtD
Betamethasone—Urticaria—Topotecan—cervical cancer	0.000115	0.0148	CcSEcCtD
Betamethasone—Abdominal pain—Topotecan—cervical cancer	0.000114	0.0148	CcSEcCtD
Betamethasone—Body temperature increased—Topotecan—cervical cancer	0.000114	0.0148	CcSEcCtD
Betamethasone—Asthenia—Topotecan—cervical cancer	0.000104	0.0134	CcSEcCtD
Betamethasone—Pruritus—Topotecan—cervical cancer	0.000102	0.0132	CcSEcCtD
Betamethasone—Diarrhoea—Topotecan—cervical cancer	9.9e-05	0.0128	CcSEcCtD
Betamethasone—Dizziness—Topotecan—cervical cancer	9.57e-05	0.0123	CcSEcCtD
Betamethasone—Vomiting—Topotecan—cervical cancer	9.2e-05	0.0119	CcSEcCtD
Betamethasone—Rash—Topotecan—cervical cancer	9.12e-05	0.0118	CcSEcCtD
Betamethasone—Dermatitis—Topotecan—cervical cancer	9.11e-05	0.0118	CcSEcCtD
Betamethasone—Headache—Topotecan—cervical cancer	9.06e-05	0.0117	CcSEcCtD
Betamethasone—Nausea—Topotecan—cervical cancer	8.59e-05	0.0111	CcSEcCtD
